Medestea USA Holding

Medestea is an Italian biotechnology and pharmaceutical company that specializes in the research, development, and commercialization of innovative health and beauty products. The company focuses on nutraceuticals, cosmeceuticals, and medical devices, often leveraging proprietary botanical extracts and advanced delivery systems. Medestea is well-known for its brands such as Santangelica and Cellasene, which target metabolic and dermatological conditions. Their research division, Medestea Biotech, conducts clinical studies to validate the efficacy of their formulations in areas like joint health and hair loss. The company operates internationally, maintaining a presence in the United States through its holding entity to manage North American distribution and partnerships.